NCT02204163View on ClinicalTrials.gov

Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

Prader-Willi Syndrome

Interventions

DRUG

Eutropin

DRUG

Genotropin

Trial Locations (3)

Unknown

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

Ajou University Hospital, Suwon

Sponsors

Lead Sponsor

LG Life Sciences

All Listed Sponsors

lead

LG Life Sciences

INDUSTRY

NCT02204163 - Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome | Biotech Hunter | Biotech Hunter